Hepatitis – Microbiology – Flashcards
Unlock all answers in this set
Unlock answers| Common features of Viral Hepatitis |
|
| Hepatitis A Virus (HAV): General |
|
| HAV: Transmission |
|
| HAV: clinical features |
Incubation period: avg = 30 days
Jaundice:
Complications: Fulminant hepatitis, cholestatic hepatitis
Typical disease: acute for weeks |
| HAV pathogenesis: |
| enters intestinal tract -> blood -> liver -> replicates in hepatocytes -> liver damge from virus and immune response -> leaves liver via bile duct -> shed in feces |
| Diagnosis of HAV infection: |
Definitive diagnosis of acute infection: α-HAV IgM in serum
Definitive diagnosis of past infection: α-HAV IgG |
| Hepatitis B Virus (HBV): General |
|
| HBV: outcomes of infections |
|
| Clinical features of HBV |
Incubation period: avg = 100 days
Jaundice: >5 yrs 30-50%
Chonic infection: more likely in children <5 yrs Acute infection more likely in adults
15-25% die of chronic liver disease |
| HBV: pathogenesis |
| entry via blood or semen -> travel to liver -> replication in liver (100days) -> liver damage due to immune response (not virus) |
| HBsAg= |
| general marker of HBV infection |
| α-HBsAb = |
| recovery and/or immunity to HBV infection |
| α-HBc IgM = |
| marker of acute infection |
| α-HBc IgG = |
| past or chronic infection |
| HBeAg = |
| active replication of virus and infectiveness |
| α-HBe = |
| virus no longer replicating |
| HBV-DNA = |
active replication of virus -more accurate than HBeAg |
| List the expected serological findings in an acute HBV infection |
HBsAg + HBeAg +/- α-HBcAg IgM + α-HBcag IgG + right after infection; - rest of the time |
| List the expected serological findings following recovery of and acute HBV infection |
HBsAg - HBeAg - α-HBsAg + α-HBcAg IgM - α-HBcAg IgG (total) + |
| List the expected serological findings in a chronic persistent HBV infection |
HBsAg + HBeAg - α-HBcAg IgM - α-HBcAg IgG (total) + α-HBeAg + DNA polymerase - |
| List the expected serological findings in a chronic active HBV infection |
HBsAg + HBeAg + α-HBcAg IgM - α-HBcAg IgG (total) + DNA polymerase + |
| Hepatitis D (delta) Virus (HDV): general |
|
| HDV: transmission and risk group |
|
| HDV: clinical features of coinfection |
severe acute disease - mostly adults low risk for chronic infection serology will show ?-HBs in later weeks |
| HDV: clinical features of superinfection |
usually from contracting HDV while person already has a chronic HBV infection
-high risk of severe chronic liver disease (chronic active or fulminant hepatitis)
serology: will continually have HDV-RNA, HBsAg, α-HDV IgM; will not have α-HBs |
| α-HDV IgM = |
acute
high titers in chronic during times of reactivation |
| HDV Ag = |
| acute or chronic HDV infection |
| α-HDV IgG = |
| declines late in acute, high titers in chronic |
| Hepatitis E Virus (HEV): general |
|
| HEV: transmission |
|
| HEV clinical features: |
Incubation: avg 40 days
Case-fatality rate: pregnant 15 - 25%
severity increases with age |
| Hepatitis G Virus |
Flavivirus; (+)ssRNA mild acute hepatitis that usually becomes chronic persistent
can be found in coinfections with HC, HBV and HIV |
| Hepatitis C Virus (HCV): General |
|
| HCV: transmission |
percutaneous route
permucosal |
| Clinical features of HCV infection |
Incubation: avg 8 - 9 weeks
Jaundice: <25% chronic infection: 70 - 85% chronic hepatitis: 60 - 70 % cirrhosis 5 - 20% (takes 10 - 20 yrs of infection) |
| Factors that promote progression of chronic HCV infection |
|
| Diagnosing HCV: |
|